Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 359841, 9 pages
http://dx.doi.org/10.1155/2014/359841
Research Article

Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats

1Department of Pharmacology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 814673461, Iran
2Department of Pharmacology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord 8815774667, Iran
3Department of Clinical Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 814673461, Iran

Received 16 June 2014; Revised 14 October 2014; Accepted 27 October 2014; Published 16 November 2014

Academic Editor: Koichiro Wada

Copyright © 2014 Mohsen Minaiyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Blumberg, J. Cho, J. Lewis, and G. Wu, “Inflammatory bowel disease: an update on the fundamental biology and clinical management,” Gastroenterology, vol. 140, no. 6, pp. 1701–1703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Zeng, J.-H. Xiao, M.-J. Chang, and J.-L. Wang, “Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-γ and inhibition of the Nf-Kb inflammatory pathway,” Molecules, vol. 16, no. 10, pp. 8552–8568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Graff, J. R. Walker, L. Lix et al., “The relationship of disease type and activity to psychological functioning and quality of life,” Clinical Gastroenterology and Hepatology, vol. 4, no. 12, pp. 1491–1501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Drossman, D. L. Patrick, C. M. Mitchell, E. A. Zagami, and M. I. Appelbaum, “Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns,” Digestive Diseases and Sciences, vol. 34, no. 9, pp. 1379–1386, 1989. View at Google Scholar · View at Scopus
  5. H. Andrews, P. Barczak, and R. N. Allan, “Psychiatric illness in patients with inflammatory bowel disease,” Gut, vol. 28, no. 12, pp. 1600–1604, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Scott, R. Bruffaerts, A. Tsang et al., “Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health surveys,” Journal of Affective Disorders, vol. 103, no. 1–3, pp. 113–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Levenstein, C. Prantera, V. Varvo et al., “Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled remission,” American Journal of Gastroenterology, vol. 95, no. 5, pp. 1213–1220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. E. A. Walker, A. N. Gelfand, M. D. Gelfand, and W. J. Katon, “Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease,” Psychological Medicine, vol. 25, no. 6, pp. 1259–1267, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Kurina, M. J. Goldacre, D. Yeates, and L. E. Gill, “Depression and anxiety in people with inflammatory bowel disease,” Journal of Epidemiology and Community Health, vol. 55, no. 10, pp. 716–720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Mikocka-Walus, D. A. Turnbull, N. T. Moulding, I. G. Wilson, J. M. Andrews, and G. J. Holtmann, “Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review,” Inflammatory Bowel Diseases, vol. 13, no. 2, pp. 225–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Persoons, S. Vermeire, K. Demyttenaere et al., “The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 2, pp. 101–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. G. Maunder and S. Levenstein, “The role of stress in the development and clinical course of inflammatory bowel disease: Epidemiological evidence,” Current Molecular Medicine, vol. 8, no. 4, pp. 247–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Sajadinejad, K. Asgari, H. Molavi, M. Kalantari, and P. Adibi, “Psychological issues in inflammatory bowel disease: an overview,” Gastroenterology Research and Practice, vol. 2012, Article ID 106502, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi, “The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in rats,” Clinics, vol. 65, no. 11, pp. 1183–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. O. M. E. Abdel-Salam, S. M. Nofal, and S. M. El-Shenawy, “Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat,” Pharmacological Research, vol. 48, no. 2, pp. 157–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. G. McCleane, “Tropical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study,” British Journal of Clinical Pharmacology, vol. 49, no. 6, pp. 574–579, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Eller, V. Vasar, J. Shlik, and E. Maron, “Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 2, pp. 445–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. O. M. Abdel-Salam, A. R. Baiuomy, and M. S. Arbid, “Studies on the anti-inflammatory effect of fluoxetine in the rat,” Pharmacological Research, vol. 49, no. 2, pp. 119–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Aricioglu, U. Buldanlioglu, G. Salanturoglu, and N. S. Ozyalcinn, “Evaluation of anti-nociceptive and anti-inflammatory effects of venlafaxine in the rat,” The Journal of the Turkish Society of Algology, vol. 17, no. 4, pp. 41–46, 2005. View at Google Scholar
  20. H. Sadeghi, V. Hajhashemi, M. Minaiyan, A. Movahedian, and A. Talebi, “A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats,” European Journal of Pharmacology, vol. 667, no. 1–3, pp. 396–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi, “Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites,” Iranian Journal of Pharmaceutical Research, vol. 10, no. 3, pp. 611–618, 2011. View at Google Scholar · View at Scopus
  22. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi, “Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats,” Inflammation Research, vol. 59, no. 12, pp. 1053–1059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Pinder, R. N. Brogden, T. M. Speight, and G. S. Avery, “Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states,” Drugs, vol. 13, no. 5, pp. 321–352, 1977. View at Publisher · View at Google Scholar · View at Scopus
  24. R. D. Porsolt, G. Anton, N. Blavet, and M. Jalfre, “Behavioural despair in rats: a new model sensitive to antidepressant treatments,” European Journal of Pharmacology, vol. 47, no. 4, pp. 379–391, 1978. View at Publisher · View at Google Scholar · View at Scopus
  25. B. R. MacPherson and C. J. Pfeiffer, “Experimental production of diffuse colitis in rats,” Digestion, vol. 17, no. 2, pp. 135–150, 1978. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Minaiyan, A. R. Ghannadi, M. Afsharipour, and P. Mahzouni, “Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats,” Research in Pharmaceutical Sciences, vol. 6, no. 1, pp. 13–21, 2011. View at Google Scholar · View at Scopus
  27. C. D. Deshmukh, B. Veeresh, and A. T. Pawar, “Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats,” Journal of Herbal Medicine and Toxicology, vol. 4, no. 2, pp. 83–87, 2010. View at Google Scholar
  28. M. Ghosh, X. Song, G. Mouneimne, M. Sidani, D. S. Lawrence, and J. S. Condeelis, “Cofilin pro-motes actin polymerization and defines the direction of cell motility,” Science, vol. 304, no. 5671, pp. 743–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Varshosaz, J. Emami, A. Fassihi et al., “Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats,” International Journal of Colorectal Disease, vol. 25, no. 10, pp. 1159–1165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yuan, W.-S. Ji, K.-X. Wu, J.-X. Jiao, L.-H. Sun, and Y.-T. Feng, “Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4578–4581, 2006. View at Google Scholar · View at Scopus
  31. A. Motavallian, M. Minaiyan, M. Rabbani et al., “Does cisapride, as a 5HT4 receptor agonist, aggravate the severity of TNBS-induced colitis in rat?” Gastroenterology Research and Practice, vol. 2012, Article ID 362536, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. L. A. Dieleman, M. J. H. J. Palmen, H. Akol et al., “Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines,” Clinical and Experimental Immunology, vol. 114, no. 3, pp. 385–391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, “Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker,” Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206–209, 1982. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Levenstein, “Stress and ulcerative colitis: convincing the doubting Thomases,” The American Journal of Gastroenterology, vol. 98, no. 10, pp. 2112–2115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. H. Niess, H. Mönnikes, A. U. Dignass, B. F. Klapp, and P. C. Arck, “Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease,” Digestion, vol. 65, no. 3, pp. 131–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. J. E. Mawdsley and D. S. Rampton, “Psychological stress in IBD: new insights into pathogenic and therapeutic implications,” Gut, vol. 54, no. 10, pp. 1481–1491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. B. E. Leonard, “The immune system, depression and the action of antidepressants,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 25, no. 4, pp. 767–780, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Rex, R. Schickert, and H. Fink, “Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats,” Pharmacology Biochemistry and Behavior, vol. 77, no. 2, pp. 303–307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Bolandghamat, A. Moghimi, and M. Iranshahi, “Effects of ethanolic extract of pine needles (Pinus eldarica Medw.) on reserpine-induced depression-like behavior in male Wistar rats,” Pharmacognosy Magazine, vol. 7, no. 27, pp. 248–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. JahaniHashemi, H. Jafari, E. Abbasi, A. Momeni, H. Esmaeily, and T. Naserpour, “The effects of hydro alcoholic-extracts garlic on depression induced by reserpine in rats,” Iranian Journal of Neurology, vol. 7, no. 26, pp. 527–534, 2009. View at Google Scholar
  41. A. R. Jurjus, N. N. Khoury, and J. M. Reimund, “Animal models of inflammatory bowel disease,” Journal of Pharmacological and Toxicological Methods, vol. 50, no. 2, pp. 81–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. O. Elson, R. B. Sartor, G. S. Tennyson, and R. H. Riddell, “Experimental models of inflammatory bowel disease,” Gastroenterology, vol. 109, no. 4, pp. 1344–1367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Tache and C. N. Bernstein, “Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect,” Gastroenterology, vol. 136, no. 7, pp. 2058–2061, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Muscat, M. Papp, and P. Willner, “Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline,” Psychopharmacology, vol. 109, no. 4, pp. 433–438, 1992. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Esmaily, A. Hosseini-Tabatabaei, R. Rahimian et al., “On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells,” Central European Journal of Biology, vol. 4, no. 2, pp. 204–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. M. Dvorak, R. A. Monahan, J. E. Osage, and G. R. Dickersin, “Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature,” Human Pathology, vol. 11, no. 6, pp. 606–619, 1980. View at Publisher · View at Google Scholar · View at Scopus
  47. T. C. Theoharides and D. E. Cochrane, “Critical role of mast cells in inflammatory diseases and the effect of acute stress,” Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-E. Ghia, P. Blennerhassett, and S. M. Collins, “Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression,” Journal of Clinical Investigation, vol. 118, no. 6, pp. 2209–2218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Hashioka, P. L. McGeer, A. Monji, and S. Kanba, “Anti-inflammatory effects of antidepressants: possibilities for preventives against alzheimer's disease,” Central Nervous System Agents in Medicinal Chemistry, vol. 9, no. 1, pp. 12–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Xie and S.-H. He, “Roles of histamine and its receptors in allergic and inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 11, no. 19, pp. 2851–2857, 2005. View at Google Scholar · View at Scopus
  51. H. Nolte, N. Spjeldnaes, A. Kruse, and B. Windelborg, “Histamine release from gut mast cells from patients with inflammatory bowel diseases,” Gut, vol. 31, no. 7, pp. 791–794, 1990. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Cavero, F. Lefèvre-Borg, and A. G. Roach, “Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats,” British Journal of Pharmacology, vol. 74, no. 1, pp. 143–148, 1981. View at Publisher · View at Google Scholar · View at Scopus